We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Sabra Healthcare REIT
SBRA
$5.13B
| $522K | ﹤0.01% |
39,754
-2,446
| -6% | -$36.1K |
|
1327
Agios Pharmaceuticals
AGIO
$1.97B
| $512K | ﹤0.01% |
18,108
-359,052
| -95% | -$9.63M |
|
1328
Bioceres Crop Solutions
BIOX
$24.6M
| – | – |
0
| – | – |
|
1329
RLI Corp
RLI
$5.56B
| $511K | ﹤0.01% |
9,976
-4,366
| -30% | -$244K |
|
1330
DTE Energy
DTE
$27.2B
| $506K | ﹤0.01% |
4,395
+84
| +2% | +$10.8K |
|
1331
Ingevity
NGVT
$2.35B
| $504K | ﹤0.01% |
8,307
+2,085
| +34% | +$140K |
|
|
LPSN
1332
DELISTED
LivePerson
LPSN
| $503K | ﹤0.01% |
3,560
+260
| +8% | +$49.8K |
|
1333
Spire
SR
$4.72B
| $498K | ﹤0.01% |
7,989
-4,533
| -36% | -$324K |
|
|
COWN
1334
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $494K | ﹤0.01% |
12,776
-36,284
| -74% | -$1.32M |
|
1335
Ziff Davis
ZD
$2.01B
| $492K | ﹤0.01% |
7,170
-1,476
| -17% | -$116K |
|
|
ALE
1336
DELISTED
Allete
ALE
| $490K | ﹤0.01% |
9,788
-605
| -6% | -$36K |
|
|
FISV
1337
Fiserv Inc
FISV
$26.3B
| $490K | ﹤0.01% |
5,242
+1,307
| +33% | +$133K |
|
1338
TransDigm Group
TDG
$59.7B
| $490K | ﹤0.01% |
934
+604
| +183% | +$360K |
|
1339
Dycom Industries
DY
$8.67B
| $485K | ﹤0.01% |
5,081
+1,906
| +60% | +$199K |
|
1340
Navient
NAVI
$913M
| $483K | ﹤0.01% |
32,861
+2,005
| +6% | +$30.6K |
|
1341
NorthWestern Energy
NWE
$4.22B
| $481K | ﹤0.01% |
9,758
-248
| -2% | -$13.6K |
|
|
NPKI
1342
NPK International
NPKI
$1.1B
| $481K | ﹤0.01% |
190,789
-89,258
| -32% | -$263K |
|
|
VMRK
1343
Vivmark Residential
VMRK
$48.7B
| $478K | ﹤0.01% |
7,106
-72
| -1% | -$5.32K |
|
1344
WaFd
WAFD
$2.43B
| $477K | ﹤0.01% |
15,895
-759
| -5% | -$24.6K |
|
1345
Welltower
WELL
$169B
| $473K | ﹤0.01% |
7,352
-122
| -2% | -$9.54K |
|
|
SMC
1346
Summit Midstream
SMC
$451M
| $473K | ﹤0.01% |
31,464
| – | – |
|
1347
AES
AES
$10.6B
| $472K | ﹤0.01% |
20,867
+3,317
| +19% | +$78.6K |
|
|
HOUS
1348
DELISTED
Anywhere Real Estate
HOUS
| $471K | ﹤0.01% |
58,094
-13,311
| -19% | -$136K |
|
1349
Ormat Technologies
ORA
$5.65B
| $471K | ﹤0.01% |
+5,464
| New | +$486K |
|
1350
SiTime
SITM
$16.5B
| $470K | ﹤0.01% |
5,964
-96,992
| -94% | -$12.5M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.